Shannon K Boi

7PUBLICATIONS
78CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)PsychopharmacologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 14, 2025
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity.

Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet

|Feb 06, 2024
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.

Terese C Hammond, Marco A Purbhoo, Sapana Kadel

|Feb 04, 2022
Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation.

Ardiana Moustaki, Jeremy Chase Crawford, Shanta Alli

|Nov 17, 2021
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.

Brooke Prinzing, Caitlin C Zebley, Christopher T Petersen

|Jul 20, 2021
BATF targets T cell exhaustion for termination.

Shannon K Boi, Xin Lan, Ben Youngblood

|Jun 02, 2021
Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice.

William J Turbitt, Shannon K Boi, Justin T Gibson

Pageof 2

Frequent Collaborators

4 joint publications

Benjamin Youngblood

2 joint publications

Mark A Exley

2 joint publications

Marc van Dijk

2 joint publications

Kah Teong Soh